These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

521 related items for PubMed ID: 16850797

  • 21. Combination therapy with ezetimibe and simvastatin to achieve aggressive LDL reduction.
    Robinson JG, Davidson MH.
    Expert Rev Cardiovasc Ther; 2006 Jul; 4(4):461-76. PubMed ID: 16918265
    [Abstract] [Full Text] [Related]

  • 22. [Sequelae of the CARDS Study. LDL of 110 mg/dl still too high?].
    Klose G.
    MMW Fortschr Med; 2004 Jun 24; 146(26):14. PubMed ID: 15529683
    [No Abstract] [Full Text] [Related]

  • 23. [Considerable LDL lowering is advantageous].
    MMW Fortschr Med; 2005 Sep 01; 147(35-36):9. PubMed ID: 16180563
    [No Abstract] [Full Text] [Related]

  • 24. A clinical focus on statins.
    Auer J, Eber B.
    Curr Opin Investig Drugs; 2001 Mar 01; 2(3):382-8. PubMed ID: 11575709
    [Abstract] [Full Text] [Related]

  • 25. Effect of aggressive versus moderate lipid-lowering therapy on myocardial ischemia: the rationale, design, and baseline characteristics of the Study Assessing Goals in the Elderly (SAGE).
    Deedwania PC, Study Assessing Goals in the Elderly steering committee and investigators.
    Am Heart J; 2004 Dec 01; 148(6):1053-9. PubMed ID: 15632893
    [Abstract] [Full Text] [Related]

  • 26. Statins for high-risk patients without heart disease or high cholesterol.
    Med Lett Drugs Ther; 2006 Jan 02; 48(1225):1-3. PubMed ID: 16374400
    [No Abstract] [Full Text] [Related]

  • 27. Safety and efficacy of Atorvastatin-induced very low-density lipoprotein cholesterol levels in Patients with coronary heart disease (a post hoc analysis of the treating to new targets [TNT] study).
    LaRosa JC, Grundy SM, Kastelein JJ, Kostis JB, Greten H, Treating to New Targets (TNT) Steering Committee and Investigators.
    Am J Cardiol; 2007 Sep 01; 100(5):747-52. PubMed ID: 17719314
    [Abstract] [Full Text] [Related]

  • 28. [Target values are more often attainable. Almost doubly so many patients with values under 100mg/dl].
    MMW Fortschr Med; 2004 Oct 28; 146(44):57. PubMed ID: 15566254
    [No Abstract] [Full Text] [Related]

  • 29. [Statin treatment in type 2 diabetes. Is it a must today?].
    Faust M.
    MMW Fortschr Med; 2003 Feb 27; 145(9):35-6. PubMed ID: 12666527
    [No Abstract] [Full Text] [Related]

  • 30. [Ezetimib plus statin combination. A strong duo].
    MMW Fortschr Med; 2002 Nov 28; 144(48):53. PubMed ID: 12532547
    [No Abstract] [Full Text] [Related]

  • 31. Aggressive low-density lipoprotein cholesterol lowering in secondary prevention of coronary heart disease.
    Clearfield M.
    Curr Atheroscler Rep; 2006 Jan 28; 8(1):7-8. PubMed ID: 16455005
    [No Abstract] [Full Text] [Related]

  • 32. Effective use of statins to prevent coronary heart disease.
    Crouch MA.
    Am Fam Physician; 2001 Jan 15; 63(2):309-20, 323-4. PubMed ID: 11201696
    [Abstract] [Full Text] [Related]

  • 33. Are statins created equal? Evidence from randomized trials of pravastatin, simvastatin, and atorvastatin for cardiovascular disease prevention.
    Zhou Z, Rahme E, Pilote L.
    Am Heart J; 2006 Feb 15; 151(2):273-81. PubMed ID: 16442888
    [Abstract] [Full Text] [Related]

  • 34. [Atorvastatin in treatment of patients with coronary heart disease and dislipidemiya and high general risk: efficiency and safety estimation. Design and main results of ATLANTIKA].
    Mareev VIu, Belenkov IuN, Oganov RG, Barbik-Zhagar B.
    Kardiologiia; 2008 Feb 15; 48(11):4-13. PubMed ID: 19076074
    [No Abstract] [Full Text] [Related]

  • 35. Therapeutic change of HMG-CoA reductase inhibitors in patients with coronary artery disease.
    Hilleman DE, Wurdeman RL, Lenz TL.
    Pharmacotherapy; 2001 Apr 15; 21(4):410-5. PubMed ID: 11310513
    [Abstract] [Full Text] [Related]

  • 36. Comparison of statins in hypertriglyceridemia.
    Stein EA, Lane M, Laskarzewski P.
    Am J Cardiol; 1998 Feb 26; 81(4A):66B-69B. PubMed ID: 9526817
    [Abstract] [Full Text] [Related]

  • 37. [Regarding LDL cholesterol: the lower, the better (interview by Dr. Dirk Einecke)].
    Nissen S.
    MMW Fortschr Med; 2004 Mar 25; 146(13):65. PubMed ID: 15219143
    [No Abstract] [Full Text] [Related]

  • 38. Rationale and design of assessment of lipophilic vs. hydrophilic statin therapy in acute myocardial infarction (the ALPS-AMI) study.
    Kashima Y, Izawa A, Aizawa K, Koshikawa M, Kasai H, Tomita T, Kumazaki S, Tsutsui H, Koyama J, Ikeda U.
    J Cardiol; 2009 Aug 25; 54(1):76-9. PubMed ID: 19632524
    [Abstract] [Full Text] [Related]

  • 39. Clinical inquiries. What is the target for low-density lipoprotein cholesterol in patients with heart disease?
    Stevermer JJ, Meadows SE.
    J Fam Pract; 2002 Oct 25; 51(10):893. PubMed ID: 12401164
    [No Abstract] [Full Text] [Related]

  • 40. Apolipoprotein modifying effects of statins and fibrate in various age groups of coronary artery disease patients.
    Sharma R, Mahajan M, Singh B, Bal BS, Kant R.
    J Indian Med Assoc; 2006 Sep 25; 104(9):492-4, 496, 498. PubMed ID: 17388006
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.